Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers.

Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, Tecleab T, Liakina V, Scarlatti G, Robb ML, Earl PL, Moss B, Wahren B, Mhalu F, Ferrari G, Sandstrom E, Biberfeld G.

AIDS Res Hum Retroviruses. 2017 Jan 27. doi: 10.1089/AID.2016.0251. [Epub ahead of print]

PMID:
28027665
2.

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.

Joachim A, Bauer A, Joseph S, Geldmacher C, Munseri PJ, Aboud S, Missanga M, Mann P, Wahren B, Ferrari G, Polonis VR, Robb ML, Weber J, Tatoud R, Maboko L, Hoelscher M, Lyamuya EF, Biberfeld G, Sandström E, Kroidl A, Bakari M, Nilsson C, McCormack S.

PLoS One. 2016 May 18;11(5):e0155702. doi: 10.1371/journal.pone.0155702. eCollection 2016.

3.

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.

Munseri PJ, Kroidl A, Nilsson C, Joachim A, Geldmacher C, Mann P, Moshiro C, Aboud S, Lyamuya E, Maboko L, Missanga M, Kaluwa B, Mfinanga S, Podola L, Bauer A, Godoy-Ramirez K, Marovich M, Moss B, Hoelscher M, Gotch F, Stöhr W, Stout R, McCormack S, Wahren B, Mhalu F, Robb ML, Biberfeld G, Sandström E, Bakari M.

PLoS One. 2015 Apr 15;10(4):e0119629. doi: 10.1371/journal.pone.0119629. eCollection 2015.

4.

Declining HIV-1 prevalence and incidence among Police Officers - a potential cohort for HIV vaccine trials, in Dar es Salaam, Tanzania.

Munseri PJ, Bakari M, Janabi M, Aris E, Aboud S, Hejdeman B, Sandstrom E.

BMC Public Health. 2013 Aug 6;13:722. doi: 10.1186/1471-2458-13-722.

5.

The bacteraemia of disseminated tuberculosis among HIV-infected patients with prolonged fever in Tanzania.

Munseri PJ, Talbot EA, Bakari M, Matee M, Teixeira JP, von Reyn CF.

Scand J Infect Dis. 2011 Sep;43(9):696-701. doi: 10.3109/00365548.2011.577802. Epub 2011 May 12.

PMID:
21563879
6.

Tuberculosis in HIV voluntary counselling and testing centres in Dar es Salaam, Tanzania.

Munseri PJ, Bakari M, Pallangyo K, Sandstrom E.

Scand J Infect Dis. 2010 Oct;42(10):767-74. doi: 10.3109/00365548.2010.495725.

PMID:
20586671
7.

Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.

Munseri PJ, Talbot EA, Mtei L, Fordham von Reyn C.

Int J Tuberc Lung Dis. 2008 Sep;12(9):1037-41.

PMID:
18713501

Supplemental Content

Loading ...
Support Center